Which genes control the defining features that make us look as we do? And how do they make it happen?
In 1990, University of California San Diego biologist William McGinnis conducted a seminal experiment that helped scientists unravel how high-level control genes called Hox genes shape our appearance features. The McGinnis experiment helped pave the way for understanding the role of Hox genes in determining the uniform appearances of species, from humans to chimpanzees to flies.
Drosophila mimica, a rare fruit fly collected from Hawaii Volcanoes National Park.
McGinnis, a professor emeritus of Cell and Developmental Biology and former dean of the Division of Biological Sciences, helped discover a defining DNA region that he termed the homeobox, a sequence within genes that directs anatomical development. Since the now-famous McGinnis experiment, evolutionary and developmental biologists have pondered how these highly influential Hox genes determine the identities of different body regions.
More than three decades later, a study published Nov. 10 as the featured cover in Science Advances and led by Ankush Auradkar, a UC San Diego postdoctoral scholar mentored by coauthor McGinnis and study senior author Ethan Bier, helps answer questions about how Hox genes function.
The now-textbook McGinnis experiment tested whether the proteins produced by a human or mouse Hox gene could function in flies. Following in these footsteps, the new study leveraged modern CRISPR gene editing to investigate whether all aspects of Hox gene function, which consists of both protein coding and control regions, could be replaced in a common laboratory fruit fly (Drosophila melanogaster) with its counterpart from a rarer Hawaiian cousin (Drosophila mimica), which has a very different face.
The gene in question, proboscipedia, would plainly reveal itself since it directs the formation of strikingly different mouth partssmooth and spongy in D. mel but more grill-like (resembling the face of the alien in Predator science fiction films) in D. mim.
Study coauthor Emily Bulger first collected the notoriously difficult-to-breed D. mim samples from Hawaii Volcanoes National Park, along with the only native fruit (Sapindus saponaria - Hawaiian soapberry) that the insects are known to eat, in order to establish a temporary colony in Biers laboratory. Auradkar then collaborated with coauthor Sushil Devkota to decipher the genome sequence of the D. mim proboscipedia gene, which was nearly 44,000 bases long. The researchers then deleted the D. mel proboscipedia gene and replaced it with the D. mim version of the same.
Electron microscopy images contrast the smooth and spongy features of the common Drosophila melanogaster fruit fly (left) and the grill-like features of its rarer cousin, the Hawaiian Drosophila mimica.
As McGinnis had predicted, the new results revealed that the graceful facial structure of D. mel emerged as the winner over the rough features of D. mim. One trait of D. mim, however, did surface during the experiment: Sensory organs called maxillary palps that stick out from the face in D. mel instead ran parallel to feeding mouthparts as they do in D. mim. Auradkar used sophisticated genetic tools to determine the basis for this difference and tracked it down to a change in the pattern by which the proboscipedia gene is activated (control region changes).
The experiments results help answer longstanding questions about whether Hox genes function as master regulatory genes that dictate different body parts in organisms. Or, as McGinnis proposed, whether Hox genes instead provide abstract positional codes and serve as scaffolds for downstream genes that best benefit the organism. Other than the maxillary palps, the new results demonstrated that McGinnis scaffolding idea proved to be the case.
William McGinnis, professor emeritus of Cell and Developmental Biology.
McGinnis says that beyond the implications for evolutionary biology, the results could help explain developmental issues rooted in fundamental human genetic processes.
These fly studies provide a window into deep evolutionary time and inform us about the mechanisms by which body plans change during evolution, said Bier. These insights may lead to a better of understanding of processes tied to congenital birth defects in humans. With the advent of powerful new CRISPR-based genome editing systems for human therapy on the horizon, new strategies might be formulated to mitigate some of the effects of these often debilitating conditions.
According to Bier, these investigations also provide an example of the intimate connection between the support of basic science and human welfare. The research described in the Science Advances paper was supported by a Paul G. Allen Frontiers Group Distinguished Investigators Award, National Institutes of Health grant R01 GM117321 and a gift from the Tata Trusts in India to the Tata Institute for Genetics and SocietyUniversity of California San Diego (TIGS-UC San Diego). The paper was authored by Ankush Auradkar, Emily Bulger, Sushil Devkota, William McGinnis and Ethan Bier.
Competing interest note: Bier has equity interest in two companies he co-founded: Synbal Inc. and Agragene, Inc., which may potentially benefit from the research results. He also serves on Synbals board of directors and the scientific advisory board for both companies.
- Overview: Gene Structure - Holland-Frei Cancer Medicine ... - December 23rd, 2021
- Bluebird, Editas: Gene Editing Stocks Had A Tough Year. Will 2022 Be Better? - Forbes - December 23rd, 2021
- Triangle gene editing firms CEO: There is a revolution occurring in medicine - WRAL TechWire - December 23rd, 2021
- Integra Therapeutics Q&A: building next-generation gene editing tools - pharmaceutical-technology.com - December 23rd, 2021
- Global Regenerative Medicine Market is Expected to Reach USD 57.08 Billion by 2027, Growing at a CAGR of 11.27% Over the Forecast Period. -... - December 23rd, 2021
- Gene Mutation Found that is Linked to the Development of Kidney Disease - Clinical OMICs News - December 23rd, 2021
- Vaccines are just the beginning for RNA. The technology is being tested on heart and liver diseases. - The Philadelphia Inquirer - December 23rd, 2021
- A look at prospects for the US gene therapy industry - BioPharma-Reporter.com - December 23rd, 2021
- Novartis to acquire Gyroscope Therapeutics, adding a one-time gene therapy that could transform care for geographic atrophy, a leading cause of... - December 23rd, 2021
- Betagenon co-founder publishes that AMPK activator O304 prevents gene expression changes and remobilisation of histone marks in islets of diet-induced... - December 23rd, 2021
- CUIMC Year in Review: Health News - Columbia University Irving Medical Center - December 23rd, 2021
- EP. 6B: Phenotypic Theranostics in the Future of Precision Medicine - Targeted Oncology - December 23rd, 2021
- Emendo Biotherapeutics and Seattle Children's Research Institute Announce Collaboration to Develop CRISPR-based Therapeutic Strategy for Severe... - December 23rd, 2021
- Open letter to employees, technologists, professionals and physicians of the Optilab laboratory medicine clusters in Quebec - McGill University Health... - December 23rd, 2021
- First variant of concern evolved to evade immune system - EurekAlert - December 23rd, 2021
- Double vaccinated and still infected with Omicron? Heres how long you should isolate - The Indian Express - December 23rd, 2021
- Genetic Tests Prompt Therapy Adjustments in Epilepsy - Medscape - December 22nd, 2021
- How to Know What Strain of COVID-19 You Have - Do Doctors Know What Variant You Have? - Prevention.com - December 22nd, 2021
- Low expression of PLAT in Breast cancer | IJGM - Dove Medical Press - December 22nd, 2021
- Outlook on the Advanced Therapy Medicinal Products CDMO Global Market to 2028 - Rising Number of Clinical Trials for ATMP is Driving Growth -... - December 22nd, 2021
- MiNA Therapeutics Appoints Two Independent Directors With Extensive Industry Experience to Support Next Phase of Growth - BioSpace - December 22nd, 2021
- New gene therapy could provide cure for sickle cell disease, according to UAB study - The Mix - December 19th, 2021
- Durham gene therapy plant to help Pfizer develop treatments for rare diseases - WRAL Tech Wire - December 19th, 2021
- Researchers zero in on therapeutic target for aggressive uterine cancer - Michigan Medicine - December 19th, 2021
- Generation Bio shares halved as hemophilia gene therapy hunt goes back to square one - FierceBiotech - December 19th, 2021
- URMC & RIT faculty awarded patent for gene transfer technology that could transform cancer therapies - URMC - December 19th, 2021
- Very important pharmacogene variants in the Blang population | PGPM - Dove Medical Press - December 19th, 2021
- Gene Sequencing Market Research, Analysis and Global Study |Roche, Johnson & Johnson, Illumina, Thermo Fisher Scientific - Digital Journal - December 19th, 2021
- Global Gene Editing Market Research Report 2021 Featuring CRISPR, GenScript, Horizon Discovery Group, Integrated DNA Technologies and New England... - December 19th, 2021
- Association between the anti-aging protein klotho with sleep | IJGM - Dove Medical Press - December 19th, 2021
- Covid-19: 7 Nigeria returnees admitted to Chennais Kings Institute of Preventive Medicine for suspected - Free Press Journal - December 19th, 2021
- Tessera Therapeutics Adds New Executives to its Leadership Team as the Company Continues to Pioneer Gene Writing Technology as New Category in Genetic... - December 13th, 2021
- Rare gene mutation in some Black Americans may allow earlier screening of heart failure - National Institutes of Health - December 13th, 2021
- Pfizer and Sangamo Announce Updated Phase 1/2 Results Showing Sustained Bleeding Control in Highest Dose Cohort Through Two Years Following Hemophilia... - December 13th, 2021
- On the hunt for new ALS drugs, researchers see progress, and a long road ahead - BioPharma Dive - December 13th, 2021
- Europe Cell and Gene Therapy Market Size to Reach Revenues of USD 2.9 Billion by 2026 - Arizton - PRNewswire - December 13th, 2021
- Researchers Dig Up Genes and Cells Related to Skull Formation in Mice - Genetic Engineering & Biotechnology News - December 13th, 2021
- Syrian refugee is thriving five years after last-gasp gene therapy - STAT - STAT - December 13th, 2021
- The perils of flawed research and the ivermectin debacle - Medical News Today - December 13th, 2021
- Roche launches the AVENIO Edge System to simplify and automate next-generation sequencing sample preparation, reduce human error and advance precision... - December 13th, 2021
- Why Does The COVID-19 Virus 'Escape' From Our Immune Systems? - Texas A&M University Today - December 13th, 2021
- Hydra DNA Reveals Theres More Than One Way to Regrow a Head - The New York Times - December 13th, 2021
- Graphite Bio Presents Overview of Phase 1/2 CEDAR Trial Evaluating Investigational Gene Editing Therapy GPH101 in Sickle Cell Disease at 63rd ASH... - December 13th, 2021
- Use of Race in Clinical Diagnosis and Decision Making: Overview and Implications - Kaiser Family Foundation - December 13th, 2021
- Identification of Significantly Expressed Gene Mutations for Automated Classification of Benign and Malignant Prostate Cancer - DocWire News - December 13th, 2021
- VUMC: Gene Discoveries Give New Hope To People Who Stutter - Cannon Courier - December 13th, 2021
- Relationship among Homocysteine, Inflammation in AIS | NDT - Dove Medical Press - December 13th, 2021
- Groundbreaking Experimental Compound Displays Effectiveness in Treating Symptoms of Autism and Alzheimers Disease - SciTechDaily - December 13th, 2021
- '90 Day Fianc: Before the 90 Days': Everything to Know About Alina's Rare Medical Condition Diastrophic Dysplasia - Showbiz Cheat Sheet - December 13th, 2021
- Cincinnati Children's teams up with CTI on cell and gene therapies - The Lane Report - December 7th, 2021
- Is 'personalised medicine' the future of healthcare? - Tatler - December 7th, 2021
- Francis Collins on medical advances, vaccine hesitancy and Americans' ill health : Shots - Health News - NPR - December 7th, 2021
- Gene Expression Analysis Market: Rise in the need for personalized medicine is likely to influence the global market - BioSpace - December 7th, 2021
- Atamyo Therapeutics Obtains First Regulatory Authorization in Europe to Initiate a Clinical Trial for ATA-100, its Gene Therapy to Treat Limb-Girdle... - December 7th, 2021
- Gyroscope Therapeutics Announces Appointment of Tony Adamis to Board of Directors - Business Wire - December 7th, 2021
- Tune Therapeutics Launches with Pioneering Epigenomic Control Platform to Master Gene Networks, Treat Broad Range of Diseases - PRNewswire - December 7th, 2021
- Rhythm Pharmaceuticals and RareStone Ltd. Announce Exclusive Licensing Agreement for the Development and Commercialization of IMCIVREE (setmelanotide)... - December 7th, 2021
- The top 10 health and medicine breakthroughs of 2021 - Popular Science - December 7th, 2021
- SNPs rs251124, rs2287926, and rs173686 with IA | NDT - Dove Medical Press - December 7th, 2021
- Potential New Therapeutic Option May Combat Drug Resistance in HER2+ Breast Cancer and Ovarian Cancer - Cancer Network - December 7th, 2021
- Penn's Medical Emergency Response Team, 'prepared for anything' | Penn Today - Penn Today - December 7th, 2021
- Gene Therapy May Reverse Hurler Syndrome, a Rare and Severe Illness in Kids - HealthDay - November 21st, 2021
- Immunosuppressants linked to severe reactions in people with common genetic profile - Stanford Medical Center Report - November 21st, 2021
- A video that originated on InfoWars is filled with falsehoods about COVID-19 vaccines - PolitiFact - November 21st, 2021
- Gene signature may give an upper hand in metastatic breast cancer - Baylor College of Medicine News - November 21st, 2021
- Lung cancer management in the era of precision medicine - Express Healthcare - November 21st, 2021
- Powerful gene-based testing by integrating long-range chromatin interactions and knockoff genotypes - pnas.org - November 21st, 2021
- Stoke Therapeutics Announces Presentations from the Company's Dravet Syndrome Program at the American Epilepsy Society 2021 Annual Meeting - Business... - November 21st, 2021
- European Commission approves Roche's Gavreto (pralsetinib) for the treatment of adults with RET fusion-positive advanced non-small cell lung cancer |... - November 21st, 2021
- Maternal cannabis use is associated with suppression of immune gene networks in placenta and increased anxiety phenotypes in offspring - pnas.org - November 21st, 2021
- Vertex Announces Reimbursement Agreement in Spain for KAFTRIO (ivacaftor/tezacaftor/elexacaftor) in Combination With Ivacaftor to Treat People With... - November 21st, 2021
- Efficacy of PARP Inhibitors as Maintenance Therapy for Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis of Randomized Controlled... - November 21st, 2021
- Gene Therapy and Genetic Engineering - MU School of Medicine - November 17th, 2021
- Gene editing: Great for medicine but ethical issues arise - November 17th, 2021
- Gene on, gene off: Chroma Medicine turns lights on with $125M to control gene expression with ex-Editas, Regeneron leaders - FierceBiotech - November 17th, 2021
- gene therapy | Description, Uses, Examples, & Safety ... - November 17th, 2021
- Sarepta Therapeutics Names Louise Rodino-Klapac, Ph.D., Head of Research and Development - Yahoo Finance - November 17th, 2021
- CRISPR Therapeutics and ViaCyte, Inc. to Start Clinical Trial of the First Gene-Edited Cell Replacement Therapy for Treatment of Type 1 Diabetes -... - November 17th, 2021
- 8 medical advances you may have missed during COVID-19 - AAMC - November 17th, 2021
- PNAS Papers on Woodrat Microbiome, Maternal Cannabis Use, Gene-Based Testing - GenomeWeb - November 17th, 2021